Market News

M Holdings Securities Stake in Gilead Sciences Com (GILD) Trimmed by $354,480; Analog Devices (ADI) Market Valuation Declined While Bp Plc Cut Its Holding

M Holdings Securities Inc decreased its stake in Gilead Sciences Inc Com (GILD) by 42.11% based on its latest 2017Q3 regulatory filing with the SEC. M Holdings Securities Inc sold 4,431 shares as the company’s stock declined 8.05% while stock markets rallied. The institutional investor held 6,091 shares of the health care company at the end of 2017Q3, valued at $493,000, down from 10,522 at the end of the previous reported quarter. M Holdings Securities Inc who had been investing in Gilead Sciences Inc Com for a number of months, seems to be less bullish one the $105.87 billion market cap company. The stock decreased 0.15% or $0.12 during the last trading session, reaching $81.04. About 4.16M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since January 19, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Bp Plc decreased its stake in Analog Devices Inc (ADI) by 41.1% based on its latest 2017Q3 regulatory filing with the SEC. Bp Plc sold 30,000 shares as the company’s stock declined 1.50% while stock markets rallied. The hedge fund held 43,000 shares of the technology company at the end of 2017Q3, valued at $3.70M, down from 73,000 at the end of the previous reported quarter. Bp Plc who had been investing in Analog Devices Inc for a number of months, seems to be less bullish one the $35.64 billion market cap company. The stock decreased 0.59% or $0.57 during the last trading session, reaching $96.67. About 1.45M shares traded. Analog Devices, Inc. (NASDAQ:ADI) has risen 45.85% since January 19, 2017 and is uptrending. It has outperformed by 29.15% the S&P500.

Among 30 analysts covering Analog Devices (NASDAQ:ADI), 18 have Buy rating, 0 Sell and 12 Hold. Therefore 60% are positive. Analog Devices had 112 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of Analog Devices, Inc. (NASDAQ:ADI) earned “Buy” rating by Jefferies on Monday, June 26. The firm earned “Buy” rating on Wednesday, July 27 by Evercore. The firm has “Buy” rating by Drexel Hamilton given on Wednesday, May 31. The stock of Analog Devices, Inc. (NASDAQ:ADI) earned “Buy” rating by SunTrust on Wednesday, August 19. B. Riley & Co maintained the stock with “Buy” rating in Wednesday, August 19 report. Sterne Agee CRT initiated the stock with “Buy” rating in Wednesday, September 9 report. Stifel Nicolaus maintained the stock with “Buy” rating in Friday, December 29 report. Nomura upgraded Analog Devices, Inc. (NASDAQ:ADI) on Thursday, August 31 to “Hold” rating. The firm has “Outperform” rating given on Thursday, October 20 by CLSA. The rating was initiated by Goldman Sachs on Thursday, June 2 with “Sell”.

Analysts await Analog Devices, Inc. (NASDAQ:ADI) to report earnings on February, 21. They expect $1.29 earnings per share, up 37.23% or $0.35 from last year’s $0.94 per share. ADI’s profit will be $475.54 million for 18.73 P/E if the $1.29 EPS becomes a reality. After $1.45 actual earnings per share reported by Analog Devices, Inc. for the previous quarter, Wall Street now forecasts -11.03% negative EPS growth.

Since August 21, 2017, it had 0 buys, and 21 sales for $17.68 million activity. $1.13 million worth of Analog Devices, Inc. (NASDAQ:ADI) was sold by CHAMPY JAMES on Tuesday, October 24. SICCHITANO KENTON J had sold 15,000 shares worth $1.32M. 7,000 Analog Devices, Inc. (NASDAQ:ADI) shares with value of $640,640 were sold by SEIF MARGARET K. Hassett Joseph also sold $944,824 worth of Analog Devices, Inc. (NASDAQ:ADI) on Friday, September 1. Real Peter also sold $369,996 worth of Analog Devices, Inc. (NASDAQ:ADI) on Wednesday, August 30. The insider Henderson Gregory N. sold 6,396 shares worth $539,439.

Investors sentiment increased to 1.21 in 2017 Q3. Its up 0.07, from 1.14 in 2017Q2. It is positive, as 45 investors sold ADI shares while 232 reduced holdings. 100 funds opened positions while 234 raised stakes. 315.41 million shares or 0.53% more from 313.75 million shares in 2017Q2 were reported. S&Co Incorporated accumulated 5,000 shares. Raymond James & owns 310,126 shares or 0.05% of their US portfolio. Bp Public Limited Co stated it has 43,000 shares or 0.13% of all its holdings. Boston Private Wealth invested in 1.14% or 342,724 shares. Manchester Cap Lc stated it has 0.03% of its portfolio in Analog Devices, Inc. (NASDAQ:ADI). Everence Capital Mngmt holds 0.14% of its portfolio in Analog Devices, Inc. (NASDAQ:ADI) for 7,094 shares. Cobblestone Capital Advsr Lc Ny holds 0.04% of its portfolio in Analog Devices, Inc. (NASDAQ:ADI) for 3,300 shares. 20,000 are owned by Estabrook Cap Mngmt. Nippon Life Insur reported 0.04% of its portfolio in Analog Devices, Inc. (NASDAQ:ADI). San Francisco Sentry Inv Grp (Ca) holds 0.1% of its portfolio in Analog Devices, Inc. (NASDAQ:ADI) for 3,474 shares. Washington, Rhode Island-based fund reported 118,876 shares. Eqis Management has 0.02% invested in Analog Devices, Inc. (NASDAQ:ADI) for 4,903 shares. Nuveen Asset Llc reported 0.05% stake. The New York-based Wellington Shields Cap Mgmt Lc has invested 0.03% in Analog Devices, Inc. (NASDAQ:ADI). 120,550 were accumulated by Pggm Invs.

Bp Plc, which manages about $2.82 billion US Long portfolio, upped its stake in Mastercard Inc A (NYSE:MA) by 19,000 shares to 140,000 shares, valued at $19.76 million in 2017Q3, according to the filing. It also increased its holding in Workday Inc Class A (NYSE:WDAY) by 24,500 shares in the quarter, for a total of 39,000 shares, and has risen its stake in Biogen Inc (NASDAQ:BIIB).

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.10, from 0.93 in 2017Q2. It is positive, as 96 investors sold GILD shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. Van Hulzen Asset Mgmt Limited Liability Co holds 7,472 shares or 0.2% of its portfolio. Biltmore Wealth Mngmt Limited Liability Corporation stated it has 0.43% in Gilead Sciences, Inc. (NASDAQ:GILD). Carl Domino accumulated 1.3% or 13,124 shares. 126,858 were reported by Cap Management Va. Palouse Management reported 92,560 shares stake. Carnegie Asset Mngmt Ltd Liability Corp has invested 0.09% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Cypress Asset Mgmt Tx holds 0.37% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 21,125 shares. 26,510 are owned by Griffin Asset Mngmt. Bluemountain Cap Management Ltd has invested 0.22% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Fayez Sarofim And Company stated it has 0.11% in Gilead Sciences, Inc. (NASDAQ:GILD). Smith Chas P Pa Cpas has invested 0.03% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Murphy Capital stated it has 0.1% in Gilead Sciences, Inc. (NASDAQ:GILD). Alpha Cubed Investments Ltd holds 30,718 shares. 15,758 are owned by Farmers And Merchants Inc. Quinn Opportunity Prtn Limited Liability Co has 63,000 shares for 0.8% of their portfolio.

Since August 1, 2017, it had 0 insider buys, and 12 sales for $43.50 million activity. MARTIN JOHN C sold $6.05 million worth of stock or 73,333 shares. Meyers James R sold $4.99M worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Thursday, August 31. Washington Robin L also sold $4.40 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 19 have Buy rating, 0 Sell and 11 Hold. Therefore 63% are positive. Gilead Sciences had 112 analyst reports since July 29, 2015 according to SRatingsIntel. The company was downgraded on Tuesday, September 5 by Credit Suisse. The company was maintained on Tuesday, October 3 by Needham. The rating was maintained by Wells Fargo with “Market Perform” on Friday, December 4. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Hold” rating given on Friday, July 21 by BMO Capital Markets. Jefferies maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Tuesday, March 15 with “Hold” rating. Stifel Nicolaus initiated the shares of GILD in report on Monday, November 14 with “Buy” rating. The firm earned “Buy” rating on Wednesday, October 4 by RBC Capital Markets. The firm has “Outperform” rating given on Wednesday, February 3 by RBC Capital Markets. The rating was maintained by J.P. Morgan on Monday, July 24 with “Buy”. Maxim Group maintained the stock with “Hold” rating in Monday, August 28 report.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on February, 6. They expect $1.67 earnings per share, down 36.74% or $0.97 from last year’s $2.64 per share. GILD’s profit will be $2.18B for 12.13 P/E if the $1.67 EPS becomes a reality. After $2.23 actual earnings per share reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -25.11% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *